Recent findings (Weihua et al, 2008) have suggested that overexpression of EGFR is associated with tumour cell proliferation and survival, and this was attributed to maintaining the intracellular glucose level through interaction and stabilisation of the sodium/glucose cotransporter 1 (SGLT1). The gene discussed is SLC5A1; the disease is neoplasm.